{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:43:45Z","timestamp":1789911825770,"version":"4.0.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.lpm.2018.06.019","type":"journal-article","created":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T22:39:19Z","timestamp":1551998359000},"page":"e101-e110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"P1","title":["Hepatitis C treatment with all-oral direct-acting antivirals: Effectiveness and tolerance in a multicenter, prospective, observational study from French general hospitals (APROVVIE, ANGH)"],"prefix":"10.1016","volume":"48","author":[{"given":"Alexandre","family":"Pariente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Arpurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9-Jean","family":"R\u00e9my","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Rosa-H\u00e9zode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Causse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Heluwaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Macaigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Henrion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Renou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Schnee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem","family":"Salloum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Hommel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Pilette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramuntxo","family":"Arotcarena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Barjonet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hortensia","family":"Lison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Bourhis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Jouannaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Pauwels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Le eaBricquir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmond","family":"Geagea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Condat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Ripault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Zanditenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"de Montigny-Lenhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Labadie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Tissot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Maringe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Cadranel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Hag\u00e8ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Lesgourgues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2018.06.019_bib0110","first-page":"590","article-title":"Treatment of chronic hepatitis C with interferon alpha and ribavirin. Results in \u201creal life\u201d","volume":"27","author":"Pariente","year":"2003","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.lpm.2018.06.019_bib0115","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/MEG.0b013e32833bb4b0","article-title":"Treatment of chronic hepatitis C with pegylated interferon and ribavirin in treatment-naive patients in \u201ctrue life\u201d: a plea in favor of independent postmarketing evaluations","volume":"22","author":"Pariente","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.lpm.2018.06.019_bib0120","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/j.gastro.2017.07.025","article-title":"Public-private partnership: targeting real-world data for hepatitis C direct-acting antivirals","volume":"153","author":"Mishra","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lpm.2018.06.019_bib0125","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0399-8320(07)89420-6","article-title":"Guidelines for the diagnosis of uncomplicated cirrhosis","volume":"31","author":"Fontaine","year":"2007","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.lpm.2018.06.019_bib0130","series-title":"Common Terminology Criteria for Adverse events (CTCAE)V 4. 03","author":"U.S. department of health and human services. National Institute of Health National Cancer Institute","year":"2010"},{"key":"10.1016\/j.lpm.2018.06.019_bib0135","first-page":"19","article-title":"KDIGO., clinical practice guideline for acute kidney, injury","volume":"2","author":"KDIGO AKI work group","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.lpm.2018.06.019_bib0140","unstructured":"AFEF. http:\/\/www.afef.asso.fr\/RECOMMANDATIONS\/recommandations_1. 01 Juin 2015, 01 Avril 2016."},{"issue":"10","key":"10.1016\/j.lpm.2018.06.019_bib0145","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0040297","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"4","author":"Vandenbroucke","year":"2007","journal-title":"Plos Med"},{"key":"10.1016\/j.lpm.2018.06.019_bib0150","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.dld.2017.01.156","article-title":"The gap between registration trials and real world in hepatitis C is closing","volume":"49","author":"Berden","year":"2017","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.lpm.2018.06.019_bib0155","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/liv.13293","article-title":"Hepatitis C: efficacy and safety in real life","volume":"37","author":"Flisiak","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.lpm.2018.06.019_bib0160","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cgh.2016.10.034","article-title":"Identification of the best direct-acting antiviral regimen fr patients with hepatitis C virus genotype 3 infection: a systematic review and meta-analysis","volume":"15","author":"Berden","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.lpm.2018.06.019_bib0165","doi-asserted-by":"crossref","first-page":"637","DOI":"10.7326\/M16-2575","article-title":"Oral direct-acting agent therapy for hepatitis C virus infection. A systematic review","volume":"166","author":"Falade-Nwulia","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2018.06.019_bib0170","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/liv.13383","article-title":"Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme","volume":"37","author":"Hezode","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.lpm.2018.06.019_bib0175","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1056\/NEJMc1505967","article-title":"Bradyarrhythmias associated with sofosbuvir treatment","volume":"373","author":"Fontaine","year":"2015","journal-title":"N Eng J Med"},{"key":"10.1016\/j.lpm.2018.06.019_bib0180","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.chest.2015.09.018","article-title":"Severe pulmonary arterial hypertension in patients treated for hepatitis C with sofosbuvir","volume":"149","author":"Renard","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2018.06.019_bib0185","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.29814","article-title":"All-oral direct-acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus\/HCV-coinfected subjects in real-world practice: Madrid coinfection registry findings","volume":"68","author":"Berenguer","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.lpm.2018.06.019_bib0190","doi-asserted-by":"crossref","first-page":"90916","DOI":"10.18632\/oncotarget.18701","article-title":"Changes in renal function indices in cirrhotic chronic hepatitis C patients treated with sofosbuvir-containing regimens","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.lpm.2018.06.019_bib0195","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/liv.13102","article-title":"Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function","volume":"36","author":"Saxena","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.lpm.2018.06.019_bib0200","unstructured":"Recommandations AFEF pour l\u2019\u00e9limination de l\u2019infection par le virus de l\u2019h\u00e9patite C en France. http:\/\/www.afef.asso.fr\/RECOMMANDATIONS\/recommandations_1"},{"issue":"1","key":"10.1016\/j.lpm.2018.06.019_bib0205","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/liv.13292","article-title":"The impact of antiviral therapy for hepatitis C on the quality of life: a perspective","volume":"37","author":"Dusheiko","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.lpm.2018.06.019_bib0210","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7326\/M17-0118","article-title":"Expansion of treatment for hepatitis C virus infection by task shifting to community-based nonspecialist providers: a nonrandomized clinical trial","volume":"167","author":"Kattakhuzy","year":"2017","journal-title":"Ann Intern Med"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498219300454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498219300454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:05:27Z","timestamp":1760105127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498219300454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0755498219300454"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2018.06.019","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C treatment with all-oral direct-acting antivirals: Effectiveness and tolerance in a multicenter, prospective, observational study from French general hospitals (APROVVIE, ANGH)","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2018.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}